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   The interest of the scientific community on inflammation has been growing steadily, recently 
favoring the comprehensive perception of inflammation as a sort of nature’s generalized way to cope 
with the environment.1 With a group of scientists, we have begun a translational analysis of the 
evolutionarily conserved process of inflammation. As a result of this work we have elaborated a “Turin 
concept” of inflammation as an evolutionary and pathologic drift. We have become interested in 
inflammation because of two main aspects. We first made the point that the clinical presentations 
(originally comprising the so-called cardinal signs of redness, swelling, and pain) by the end of the 2nd 
World War have left, as the legacy, a creeping form2 made of mildly relapsing fever, weakness, and 
elevated C-reactive protein, somewhat matching the contemporary overgrowth of “autoimmune” 
affections of a rheumatologic interest.3 Today, Western Societies are being plagued with such disorders, 
making important socio-economic issues. On this line, the appreciation of acute/chronic inflammation 
as an evolutionary carver of life has become of age.4 Secondly, inflammatory markers have now been 
found in unsuspected areas including neuropsychiatry.5 In this case, patient’s loss of the acquaintances 
with the outer world is paralleled by inflammation marking the malaise at the organic level. Notably, 
inflammation is accredited with both archaic and current negative effects on the central nervous system 
(CNS). Our ancestors experienced historical phases of cerebral weight loss contextually to waves of 
inflammation,6 whereas modern psychiatrists do reckon that inflamed psychiatric individuals are likely 
to be resistant to standard anti-psychiatric drugs.7 At the gut level, inflammatory signals cannot be 
ignored, in view of the crucial role played by the immune system in a barrier organ such as the gut.8 
Examples of these statements might be the puzzling role of the inflammatory post prandial reactions,9 
the double-sword work of the inflammasomes,10 and the patrolling action of the sub epithelial 
lymphocytes.11 On these stages, inflammation is surprisingly being revealed to swing between overt 
reaction (potentially a host tissue damage) and smart tolerance (protecting host).12 Moreover, one can 
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airway lymphocyte circuits13 through the effects of the still largely unknown microbiome. Wrapping up 
the notes collected above, one can see inflammation as a universally “magmatic” drift: from time to 
time permissive conditions may favor its materialization to defined clinical conditions and peculiar 
consequences. Parodontitis,14 and, intriguingly enough, Helicobacter pylori infection,15 might originate 
CNS degeneration with Parkinson’s like features; the inflammatory bowel diseases (IBDs)16 may stem 
from imbalance of the inflammation physiologically patrolling the borders, and may be at the basis of 
significant inflammation beyond the same borders;17 as an accompaniment to psychiatric disorders it 
may underscore individual’s defective adaptation to the surrounding world; all the way to the indolent 
yet painful malaise of today’s mankind.3 
   Finally, we are just at the beginning of the road towards the implication of certain inflammatory 
markers as spies of our life expectancy. The intellectual icon of inflammation is now steadily 
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